Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors

Our understanding of somatic alterations in colon cancer has evolved from a concept of a series of events taking place in a single sequence to a recognition of multiple pathways. An oncogenetic tree is a model intended to describe the pathways and sequence of somatic alterations in carcinogenesis without assuming that tumors will fall in mutually exclusive categories. We applied this model to data on colon tumor somatic alterations. An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at CpG sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population‐based series. Oncogenetic tree analysis resulted in a reproducible tree with three branches. The model represents methylation of MINT markers as initiating a branch and predisposing to MSI, methylation of MHL1 and TP16, and BRAF mutation. APC mutation is the first alteration in an independent branch and is followed by TP53 mutation. KRAS2 mutation was placed a third independent branch, implying that it neither depends on, nor predisposes to, the other alterations. Individual tumors were observed to have alteration patterns representing every combination of one, two, or all three branches. The oncogenetic tree model assumptions are appropriate for the observed heterogeneity of colon tumors, and the model produces a useful visual schematic of the sequence of events in pathways of colon carcinogenesis. © 2008 Wiley‐Liss, Inc.

[1]  M. Leppert,et al.  Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. , 2001, The American journal of pathology.

[2]  A. Børresen-Dale,et al.  TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  Minoru Toyota,et al.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.

[4]  K. Kawakami,et al.  BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status , 2006, Molecular Cancer.

[5]  D. Roder,et al.  Somatic mutations, acetylator status, and prognosis in colorectal cancer , 1998, Gut.

[6]  R. Goldbohm,et al.  Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. , 2008, Carcinogenesis.

[7]  B. Iacopetta,et al.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands , 2002, Gut.

[8]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[9]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[10]  M. Slattery,et al.  Microsatellite instability in colorectal adenomas. , 1997, Gastroenterology.

[11]  M. Leppert,et al.  BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. , 1999, The American journal of pathology.

[12]  F. Haller,et al.  An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications , 2007, The Journal of pathology.

[13]  N. Matsubara,et al.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.

[14]  Feng Jiang,et al.  Distance-Based Reconstruction of Tree Models for Oncogenesis , 2000, J. Comput. Biol..

[15]  R. Wolff,et al.  Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer , 2007, International journal of cancer.

[16]  R. Wolff,et al.  APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer , 2007, Molecular Cancer Research.

[17]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[18]  K. Anderson,et al.  Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. , 2000, Mutation research.

[19]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[20]  Yan Jiang.  Number of monthly hits to WJG articles linked to PubMed surpasses 70000 , 2007 .

[21]  Jorma Isola,et al.  Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.

[22]  A. Schäffer,et al.  Graph models of oncogenesis with an application to melanoma. , 2001, Journal of theoretical biology.

[23]  H. Kraemer.  Correlation coefficients in medical research: from product moment correlation to the odds ratio , 2006, Statistical methods in medical research.

[24]  Alejandro A Schäffer,et al.  Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression , 2002, Genes, chromosomes & cancer.

[25]  N. Petrelli,et al.  p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma , 2000, Cancer.

[26]  Feng Jiang,et al.  Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data , 1999, J. Comput. Biol..

[27]  M. Leppert,et al.  Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. , 2000, Journal of the National Cancer Institute.

[28]  Richard Desper,et al.  Construction and analysis of tree models for chromosomal classification of diffuse large B-cell lymphomas. , 2007, World journal of gastroenterology.

[29]  J. Potter,et al.  Energy balance and colon cancer--beyond physical activity. , 1997, Cancer research.

[30]  M. O'brien,et al.  Comparison of Microsatellite Instability, CpG Island Methylation Phenotype, BRAF and KRAS Status in Serrated Polyps and Traditional Adenomas Indicates Separate Pathways to Distinct Colorectal Carcinoma End Points , 2006, The American journal of surgical pathology.

[31]  K. Anderson,et al.  Lifestyle factors and Ki-ras mutations in colon cancer tumors. , 2001, Mutation research.

[32]  A. Norman,et al.  Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. , 1998, Journal of the National Cancer Institute.

[33]  K. Boucher,et al.  Estimating an oncogenetic tree when false negatives and positives are present. , 2002, Mathematical biosciences.

[34]  M. Slattery,et al.  Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas. , 1997, The American journal of pathology.

[35]  M. Slattery,et al.  Energy Balance and Rectal Cancer: An Evaluation of Energy Intake, Energy Expenditure, and Body Mass Index , 2003, Nutrition and cancer.

[36]  G. Gaudernack,et al.  K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. , 1994, British Journal of Cancer.

[37]  R. Wolff,et al.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.

[38]  D. Neuberg,et al.  Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292) , 1997, The cancer journal from Scientific American.

[39]  D. Hose,et al.  Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics , 2005, Genes, chromosomes & cancer.

[40]  A. Schäffer,et al.  Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. , 2000, Cancer research.

[41]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[42]  G. Watanabe,et al.  APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer , 2006, International journal of cancer.

[43]  A. Schäffer,et al.  Construction of tree models for pathogenesis of nasopharyngeal carcinoma , 2004, Genes, chromosomes & cancer.

[44]  B. Iacopetta,et al.  Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation. , 2000, European journal of cancer.

[45]  M. Leppert,et al.  Prognostic significance of p53 mutations in colon cancer at the population level , 2002, International journal of cancer.

[46]  G. Deng,et al.  BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal Cancer , 2004, Clinical Cancer Research.

[47]  M. Leppert,et al.  Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[49]  R. Ward,et al.  CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. , 2002, Gastroenterology.

[50]  M. Leppert,et al.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. , 2001, Gastroenterology.

[51]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[52]  J. Coxhead,et al.  Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Bunn,et al.  Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. , 1998, Cancer research.

[54]  M. Leppert,et al.  Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. , 2000, Cancer research.

[55]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[56]  K. Anderson,et al.  Diet activity, and lifestyle associations with p53 mutations in colon tumors. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[57]  K. Anderson,et al.  Dietary intake and microsatellite instability in colon tumors , 2001, International journal of cancer.

[58]  R. Ward,et al.  Colorectal cancer: a model for epigenetic tumorigenesis , 2006, Gut.

[59]  N. Matsubara,et al.  Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.